EXO Biologics
Romain du Hecquet de Rauville is an accomplished professional in the biotechnology sector, currently serving as Chief Business Officer at both EXO Biologics and ExoXpert since November 2023, and as Founder of Bio-perspectives. With extensive experience in business development and strategy, Romain previously held the position of VP Business Development at EXOTHERA, where Romain contributed to the establishment of a leading CDMO for viral vectors. Romain's career includes significant roles at MaSTherCell, culminating in a Business Director role leading to the company’s acquisition by Catalent for $315 million. Romain's academic background includes a Master's degree in Biotechnology from Polytech Marseille and a double diploma in Project Management and Strategy from KEDGE Business School.
This person is not in the org chart
This person is not in any teams
EXO Biologics
EXO Biologics is a Belgian clinical-stage biotechnology company focusing on researching and developing novel sub-cellular therapeutic candidates based on exosomes. Exo Biologics mission is to provide affordable and accessible exosomes therapies to patients with unmet medical needs. Exo Biologics has strong partnerships and influential networks for collaborating and researching new medical treatments, including research centers, public universities, and private partners.